This observational study examines the use of glucose and lipid testing in Medicaid patients receiving antipsychotic therapy.
This study discusses the association between levels of high-sensitivity C-reactive protein and general psychological distress symptoms.
This population epidemiology study of patients with schizophrenia uses Medicaid data to compare overall and cause-specific mortality rates for adults with schizophrenia vs the US general population between 2001 and 2007.
Lee et al conduct a cross-sectional study to determine the synergistic effects of amyloid burden and cerebrovascular disease on cognition in patients with subcortical vascular mild cognitive impairment.
In a retrospective cohort study, Bobo and coauthors compare the risk of type 2 diabetes in children and youth 6 to 24 years of age for recent initiators of antipsychotic drugs vs propensity score–matched controls who had recently another psychotropic medication.